Safety and Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD and Previously Treated With Extended-Release Methylphenidate Therapy

This study has been completed.

Study NCT00151983 Information provided by Shire Pharmaceutical Development

First Received: September 7, 2005 Last Updated: November 2, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	July 2006
Estimated Primary Completion Date:	No date given

No publications provided by Shire Pharmaceutical Development

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Arnold LE, Bozzolo DR, Hodgkins P, McKay M, Beckett-Thurman L, Greenbaum M, Bukstein O, Patel A. Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion. Curr Med Res Opin. 2010 Jan;26(1):129-37.